Scripts for science: A new wrinkle on academic ties with industry

Annals of Neurology

Volumn 64, Issue 4, 2008, Pages

  Hauser, Stephen L ^a   Johnston, S Claiborne ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CONFLICT OF INTEREST; DRUG INDUSTRY; DRUG MARKETING; EDITORIAL; FINANCIAL MANAGEMENT; MEDICAL PRACTICE; PRESCRIPTION; PRIORITY JOURNAL; UNITED STATES;

ACADEMIES AND INSTITUTES; CONFLICT OF INTEREST; INDUSTRY; RESEARCH SUPPORT AS TOPIC; SCIENCE;

EID: 55849111879     PISSN: 03645134     EISSN: 15318249     Source Type: Journal    
DOI: 10.1002/ana.21588     Document Type: Editorial

References (9)

1. Fugh-Berman A, Ahari S. Following the script: how drug reps make friends and influence doctors. PLoS Med 2007;4:621.
2. Brennan TA, Rothman DJ, Blank L, et al. Health industry practices that create conflicts of interest: a policy proposal for academic medical centers. JAMA 2006;295:429.
3. Steinbrook R. Disclosure of industry payments to physicians. N Engl J Med 2008;359:559.
4. Hauser SL, Johnston SC. Of ghosts and sirens: the subtlest lures of industry. Ann Neurol 2007;61:A11.
5. Greene JA. Pharamaceutical marketing research and the prescribing physician. Ann Intern Med 2007;146:742.
6. Elliott C. The drug pushers. Atlantic Monthly, April 2006.
7. Fugh-Berman A. Prescription tracking and public health. J Gen Intern Med 2008;23:1277.
8. Steinbrook R. For sale: physicians' prescribing data. N Engl J Med 2006;354:2745.
9. Johnston SC, Hauser SL. A status report on neuroscience research, without grade inflation. Ann Neurol 2006;60:A9.